Personal Home Page

http://www.f1000biology.com/about/biography/1036539237111759#biography

Articles in Scholarly Journals [Incomplete List]

1. Is Cleft Lip and Palate Ever Isolated?: Phenotype Is in the Eye of the Beholder
   Archives of Pediatrics and Adolescent Medicine, vol. 161, no. 8, pp. 811–812, 2007
2. Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations
   American Journal of Medical Genetics Part A, vol. 143A, no. 7, pp. 678–686, 2007
3. Sustained formation of a-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-a, but not NADPH oxidase
   Free Radical Biology and Medicine, vol. 42, no. 3, pp. 335–342, 2007
4. The Flame Retardants, Polybrominated Diphenyl Ethers, Are Pregnane X Receptor Activators
   Toxicological Sciences, vol. 97, no. 1, pp. 94–102, 2007
5. Toward a Checklist for Exchange and Interpretation of Data from a Toxicology Study
   Toxicological Sciences, vol. 99, no. 1, pp. 26–34, 2007
6. WY-14,643 Induced Cell Proliferation and Oxidative Stress in Mouse Liver are Independent of NADPH Oxidase
   Toxicological Sciences, vol. 98, no. 2, pp. 366–374, 2007
7. Multicenter Study of Acetaminophen Hepatotoxicity Reveals the Importance of Biological Endpoints in Genomic Analyses
   Toxicological Sciences, vol. 99, no. 1, pp. 326–337, 2007
8. Phthalate-Induced Liver Protection against Deleterious Effects of the Th1 Response: A Potentially Serious Health Hazard
   PPAR Research, vol. 2007, Article ID 49671, 6 pages, 2007
9. Severity of Skull Malformation Is Unrelated to Presurgery Neurobehavioral Status of Infants With Sagittal Synostosis
   The Cleft Palate-Craniofacial Journal, vol. 44, no. 5, p. 548, 2007
10. New Scaphocephaly Severity Indices of Sagittal Craniosynostosis: A Comparative Study With Cranial Index Quantifications
    The Cleft Palate-Craniofacial Journal, vol. 43, no. 2, p. 211, 2006
11. Journal of Carcinogenesis, vol. 5, no. 1, p. 26, 2006
12. IEEE Transactions on Pattern Analysis and Machine Intelligence, vol. 28, no. 1, pp. 75–90, 2006
13. Putting the Fun Into Functional Toxicogenomics
    Toxicological Sciences, vol. 92, no. 2, pp. 347–348, 2006
14. Phenotypic Anchoring of Acetaminophen-Induced Oxidative Stress with Gene Expression Profiles in Rat Liver
    Toxicological Sciences, vol. 93, no. 1, pp. 213–222, 2006
15. Modes of Action and Species-Specific Effects of Di-(2-ethylhexyl)Phthalate in the Liver
    Critical Reviews in Toxicology, vol. 36, no. 5, pp. 459–479, 2006
16. Three-dimensional ultrasonography is superior to 2-dimensional ultrasonography in the detection of orofacial clefts during the second trimester of pregnancy
    Journal of Evidence Based Dental Practice, vol. 6, no. 4, pp. 278–279, 2006
17. Neurodevelopment of children with single suture craniosynostosis: a review
    Child's Nervous System, vol. 23, no. 3, pp. 269–281, 2006
18. Intracellular Retention, Degradation, and Signaling of Glycosylation-deficient FGFR2 and Craniosynostosis Syndrome-associated FGFR2C278F
    Journal of Biological Chemistry, vol. 281, no. 37, pp. 27292–27305, 2006
19. Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminalRUNX2 mutations
    Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 76, no. 2, pp. 78–85, 2006
20. Lymphocytopenia in Children With Lymphatic Malformation
    Archives of Otolaryngology - Head and Neck Surgery, vol. 132, no. 1, pp. 93–97, 2006
21. Skeletal changes in epidermal nevus syndrome: Does focal bone disease harbor clues concerning pathogenesis?
    American Journal of Medical Genetics Part A, vol. 139A, no. 2, pp. 67–77, 2005
22. Pregnancy outcomes after maternal exposure to simvastatin and lovastatin
    Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 73, no. 11, pp. 888–896, 2005
23. In vitro differentiation profile of osteoblasts derived from patients with Saethre?Chotzen syndrome
    Bone, vol. 36, no. 4, pp. 627–634, 2005
24. Neurodevelopmental Implications of "Deformational" Plagiocephaly
    Journal of Developmental & Behavioral Pediatrics, vol. 26, no. 5, pp. 379–389, 2005
25. Differential Expression of CYP1A, 2B, and 3A Genes in the F344 Rat following Exposure to a Polybrominated Diphenyl Ether Mixture or Individual Components
    Toxicological Sciences, vol. 88, no. 1, pp. 127–133, 2005
26. Chemical Effects in Biological Systems--Data Dictionary (CEBS-DD): A Compendium of Terms for the Capture and Integration of Biological Study Design Description, Conventional Phenotypes, and 'Omics Data
    Toxicological Sciences, vol. 88, no. 2, pp. 585–601, 2005
27. Surgical Site Infections after Pediatric Intracranial Surgery for Craniofacial Malformations: Frequency and Risk Factors
    Neurosurgery, vol. 56, no. 4, pp. 733–739, 2005
28. Multisite Study of Infants With Single-Suture Craniosynostosis: Preliminary Report of Presurgery Development
    The Cleft Palate-Craniofacial Journal, vol. 42, no. 4, p. 377, 2005
29. MDCT Diagnosis of the Child with Posterior Plagiocephaly
    American Journal of Roentgenology, vol. 185, no. 5, pp. 1342–1346, 2005
30. Differential Diagnosis of the Trapezoid-Shaped Head
    The Cleft Palate-Craniofacial Journal, vol. 41, no. 1, p. 13, 2004
31. Journal of Carcinogenesis, vol. 3, no. 1, p. 9, 2004
32. Gene Expression Profiling of Rat Livers Reveals Indicators of Potential Adverse Effects
    Toxicological Sciences, vol. 80, no. 1, pp. 193–202, 2004
33. Applying Toxicogenomics in Mechanistic and Predictive Toxicology
    Toxicological Sciences, vol. 83, no. 2, pp. 205–206, 2004
34. Progressive Postnatal Craniosynostosis and Increased Intracranial Pressure
    Plastic and Reconstructive Surgery, vol. 113, no. 5, pp. 1313–1323, 2004
35. Expression of Base Excision DNA Repair Genes Is a Sensitive Biomarker for in Vivo Detection of Chemical-induced Chronic Oxidative Stress: Identification of the Molecular Source of Radicals Responsible for DNA Damage by Peroxisome Proliferators
    Cancer Research, vol. 64, no. 3, pp. 1050–1057, 2004
36. Application of Toxicogenomics to Toxicology: Basic Concepts in the Analysis of Microarray Data
    Toxicologic Pathology, vol. 32, no. 6, pp. 72–83, 2004
37. Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens
    Carcinogenesis, vol. 26, no. 3, pp. 689–699, 2004
38. Empirical evaluation of data transformations and ranking statistics for microarray analysis
    Nucleic Acids Research, vol. 32, no. 18, pp. 5471–5479, 2004
39. Analytical Chemistry, vol. 76, no. 14, pp. 4044–4049, 2004
40. Familial acromelic frontonasal dysostosis: Autosomal dominant inheritance with reduced penetrance
    American Journal of Medical Genetics, vol. 128A, no. 4, pp. 374–382, 2004
41. Cleft-palate lateral synechia syndrome: Insight into the phenotypic spectrum of Fryns syndrome?
    Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 67, no. 6, pp. 460–466, 2003
42. Ultrasound screening of the lambdoid suture in the child with posterior plagiocephaly
    Pediatric Radiology, vol. 33, no. 9, pp. 630–636, 2003
43. Primary pulmonary dysgenesis in velocardiofacial syndrome: A second patient
    American Journal of Medical Genetics, vol. 121A, no. 2, pp. 177–179, 2003
44. Increased risk for developmental delay in Saethre-Chotzen syndrome is associated with TWIST deletions: an improved strategy for TWIST mutation screening
    Human Genetics, vol. 114, no. 1, pp. 68–76, 2003
45. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643
    Carcinogenesis, vol. 24, no. 4, pp. 757–770, 2003
46. Workshop Overview: Use of Genomic Data in Risk Assessment
    Toxicological Sciences, vol. 73, no. 2, pp. 209–215, 2003
47. Journal of Carcinogenesis, vol. 2, no. 1, p. 2, 2003
48. A Child With Saethre-Chotzen Syndrome, Sensorineural Hearing Loss, and a TWIST Mutation
    The Cleft Palate-Craniofacial Journal, vol. 39, no. 1, p. 110, 2002
49. Peroxisome Proliferators Do Not Activate the Transcription Factors AP-1, Early Growth Response-1, or Heat Shock Factors 1 and 2 in Rats or Hamsters
    Toxicological Sciences, vol. 69, no. 1, pp. 139–148, 2002
50. A Mouse Is Not a Rat Is Not a Human: Species Differences Exist
    Toxicological Sciences, vol. 70, no. 2, pp. 157–158, 2002
51. Outcomes of Prenatal Antidepressant Exposure
    American Journal of Psychiatry, vol. 159, no. 12, pp. 2055–2061, 2002
52. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of butyl benzyl phthalate1
    Reproductive Toxicology, vol. 16, no. 5, pp. 453–487, 2002
53. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-hexyl phthalate1
    Reproductive Toxicology, vol. 16, no. 5, pp. 709–719, 2002
54. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-octyl phthalate1
    Reproductive Toxicology, vol. 16, no. 5, pp. 721–734, 2002
55. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-n-butyl phthalate1
    Reproductive Toxicology, vol. 16, no. 5, pp. 489–527, 2002
56. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-isononyl phthalate1
    Reproductive Toxicology, vol. 16, no. 5, pp. 679–708, 2002
57. NTP center for the evaluation of risks to human reproduction phthalates expert panel reports
    Reproductive Toxicology, vol. 16, no. 5, p. 451, 2002
58. NTP Center for the Evaluation of Risks to Human Reproduction: phthalates expert panel report on the reproductive and developmental toxicity of di-isodecyl phthalate1
    Reproductive Toxicology, vol. 16, no. 5, pp. 655–678, 2002
59. Pulmonary agenesis: Expansion of the VCFS phenotype
    American Journal of Medical Genetics, vol. 113, no. 1, pp. 89–92, 2002
60. Determination of tamoxifen and metabolites in mouse fetal tissue using nonaqueous capillary electrophoresis
    ELECTROPHORESIS, vol. 23, no. 3, p. 502, 2002
61. Effect of peroxisome proliferators on the methylation and protein level of the c-myc protooncogene in B6C3F1 mice liver
    Journal of Biochemical and Molecular Toxicology, vol. 16, no. 1, pp. 41–47, 2002
62. Hepatic Expression of Polymerase ß, Ref-1, PCNA, and Bax in WY 14,643-Exposed Rats and Hamsters
    Experimental and Molecular Pathology, vol. 73, no. 3, pp. 209–219, 2002
63. Effects of Peroxisome Proliferators on Glutathione and Glutathione-Related Enzymes in Rats and Hamsters
    Toxicology and Applied Pharmacology, vol. 171, no. 1, pp. 27–37, 2001
64. Hemifacial myohyperplasia: Description of a new syndrome
    American Journal of Medical Genetics, vol. 103, no. 4, pp. 326–333, 2001
65. Century of Jackson-Weiss syndrome: Further definition of clinical and radiographic findings in ?lost? descendants of the original kindred
    American Journal of Medical Genetics, vol. 100, no. 4, pp. 315–324, 2001
66. AnotherTWIST on Baller-Gerold syndrome
    American Journal of Medical Genetics, vol. 104, no. 4, pp. 323–330, 2001
67. Nature Genetics, vol. 28, no. 1, pp. 37–41, 2001
68. Comparison of the mutant frequencies and mutation spectra of three non-genotoxic carcinogens, oxazepam, phenobarbital, and Wyeth 14,643, at the ?cII locus in Big Blue® transgenic mice
    Biochemical Pharmacology, vol. 62, no. 6, pp. 685–692, 2001
69. 14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice
    Food and Chemical Toxicology, vol. 39, no. 4, pp. 303–316, 2001
70. New models for assessing carcinogenesis: An ongoing process
    Toxicology Letters, vol. 120, no. 1-3, pp. 187–198, 2001
71. Inhibition of Apoptosis: A Potential Mechanism for Syndromic Craniosynostosis
    Plastic and Reconstructive Surgery, vol. 107, no. 2, pp. 425–432, 2001
72. Effects of Peroxisome Proliferators on Antioxidant Enzymes and Antioxidant Vitamins in Rats and Hamsters
    Toxicological Sciences, vol. 60, no. 2, pp. 271–278, 2001
73. Differential Activation of Hepatic NF-kappaB in Rats and Hamsters by the Peroxisome Proliferators Wy-14,643, Gemfibrozil, and Dibutyl Phthalate
    Toxicological Sciences, vol. 62, no. 1, pp. 20–27, 2001
74. INHALATION TOXICITY STUDIES OF THE a,ß-UNSATURATED KETONES: Ethyl Vinyl Ketone
    Inhalation Toxicology, vol. 13, no. 8, pp. 633–658, 2001
75. Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency
    Carcinogenesis, vol. 21, no. 12, pp. 2141–2145, 2000
76. Subchronic administration of phenobarbital alters the mutation spectrum of lacI in the livers of Big Blue® transgenic mice
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 448, no. 1, pp. 69–80, 2000
77. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue® transgenic mice
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 452, no. 2, pp. 197–210, 2000
78. Journal of Agricultural and Food Chemistry, vol. 48, no. 8, pp. 3620–3632, 2000
79. Rapid analysis of base-pair substitutions induced by mutagenic drugs through their oxygen radical or epoxide derivatives
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 470, no. 1, pp. 11–18, 2000
80. Tris(2,3-dibromopropyl)phosphate causes a gradient of mutations in the cortex and outer and inner medullas of the kidney oflacI transgenic rats
    Environmental and Molecular Mutagenesis, vol. 36, no. 1, pp. 1–4, 2000
81. Clavicular hypoplasia, zygomatic arch hypoplasia, and micrognathia: A newly defined syndrome
    American Journal of Medical Genetics, vol. 92, no. 3, pp. 200–205, 2000
82. Transmission of the dysgnathia complex from mother to daughter
    American Journal of Medical Genetics, vol. 95, no. 3, pp. 269–274, 2000
83. Molecular and Cellular Biochemistry, vol. 201, no. 1/2, pp. 25–32, 1999
84. Oxazepam is mutagenic in vivo in Big Blue(R) transgenic mice
    Carcinogenesis, vol. 20, no. 7, pp. 1315–1321, 1999
85. Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue® Rat2 embryonic fibroblasts
    Mutagenesis, vol. 13, no. 5, pp. 487–497, 1998
86. Cytogenetic characterization of the transgenic Big Blue® Rat2 and Big Blue® mouse embryonic fibroblast cell lines
    Mutagenesis, vol. 13, no. 6, pp. 649–653, 1998
87. Genetic Heterogeneity of Saethre-Chotzen Syndrome, Due to TWIST and FGFR Mutations
    The American Journal of Human Genetics, vol. 62, no. 6, pp. 1370–1380, 1998
88. Analysis of the human Sonic Hedgehog coding and promoter regions in sacral agenesis, triphalangeal thumb, and mirror polydactyly
    Human Genetics, vol. 102, no. 4, pp. 387–392, 1998
89. Normal development of dental innervation and nerve/tissue interactions in the colony-stimulating factor-1 deficient osteopetrotic mouse
    Developmental Dynamics, vol. 211, no. 1, pp. 52–59, 1998
90. Pharmacodynamic Responses of F344 Rats to the Mouse Hepatocarcinogen Oxazepam in a 90-Day Feed Study
    Toxicology and Applied Pharmacology, vol. 149, no. 1, pp. 41–48, 1998
91. Comparison of Dose–Response Relationships for Induction of Lipid Metabolizing and Growth Regulatory Genes by Peroxisome Proliferators in Rat Liver,
    Toxicology and Applied Pharmacology, vol. 151, no. 2, pp. 254–261, 1998
92. A comparison of liver protein changes in mice and hamsters treated with the peroxisome proliferator Wy-14,643
    Electrophoresis, vol. 19, no. 14, pp. 2498–2505, 1998
93. Pathogenesis of ectrodactyly in theDactylaplasia mouse: Aberrant cell death of the apical ectodermal ridge
    Teratology, vol. 56, no. 4, pp. 262–270, 1997
94. Pulmonary agenesis: A predictor of ipsilateral malformations
    American Journal of Medical Genetics, vol. 70, no. 4, pp. 391–398, 1997
95. Determination of tamoxifen and metabolites in serum by capillary electrophoresis using a nonaqueous buffer system
    Journal of Chromatography B: Biomedical Sciences and Applications, vol. 695, no. 1, pp. 181–185, 1997
96. Evidence against peroxisome proliferation-induced hepatic oxidative damage Levels of esterified isoprostanes in livers of mice fed a diet containing [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY-14,643)
    Biochemical Pharmacology, vol. 53, no. 9, pp. 1369–1374, 1997
97. Overlapping Expression and Redundant Activation of Mesenchymal Fibroblast Growth Factor (FGF) Receptors by Alternatively Spliced FGF-8 Ligands
    Journal of Biological Chemistry, vol. 272, no. 6, pp. 3733–3738, 1997
98. Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens
    Mutation Research/Reviews in Genetic Toxicology, vol. 365, no. 1-3, pp. 59–69, 1996
99. Biochemical Effects of the Mouse Hepatocarcinogen Oxazepam: Similarities to Phenobarbital
    Fundamental and Applied Toxicology, vol. 29, no. 1, pp. 147–154, 1996
100. Biochemical Effects of the Mouse Hepatocarcinogen Oxazepam: Similarities to Phenobarbital
     Toxicological Sciences, vol. 29, no. 1, pp. 147–154, 1996
101. Metabolic Requirements for the Hepatocellular Proliferation Induced by Peroxisome Proliferators.
     Annals of the New York Academy of Sciences, vol. 804, no. 1 Peroxisomes, pp. 725–727, 1996
102. The Differential Diagnosis of Posterior Plagiocephaly: True Lambdoid Synostosis versus Positional Molding
     Plastic & Reconstructive Surgery, vol. 98, no. 5, pp. 765–774, 1996
103. The Hepatocarcinogen Methapyrilene but Not the Analog Pyrilamine Induces Sustained Hepatocellular Replication and Protein Alterations in F344 Rats in a 13-Week Feed Study
     Toxicology and Applied Pharmacology, vol. 131, no. 2, pp. 216–223, 1995
104. Rotenone, an anticarcinogen, inhibits cellular proliferation but not peroxisome proliferation in mouse liver
     Cancer Letters, vol. 95, no. 1-2, pp. 93–97, 1995
105. Cell proliferation as a determining factor for the carcinogenicity of chemicals:Studies with mutagenic carcinogens and mutagenic noncarcinogens
     Toxicology Letters, vol. 82-83, pp. 9–14, 1995
106. Activity of hepatic drug metabolizing enzymes following oxazepam-dosed feed treatment in B6C3F1 mice
     Toxicology Letters, vol. 76, no. 3, pp. 251–256, 1995
107. Early Responses of the Liver of B6C3F1 Mice to the Hepatocarcinogen Oxazepam
     Toxicology and Applied Pharmacology, vol. 124, no. 1, pp. 31–38, 1994
108. Relationship of Carcinogenicity and Cellular Proliferation Induced by Mutagenic Noncarcinogens vs Carcinogens III. Organophosphate Pesticides vs Tris(2,3-dibromopropyl)phosphate
     Fundamental and Applied Toxicology, vol. 23, no. 3, pp. 363–369, 1994
109. From gastrulation to neurulation: Transition in retinoic acid sensitivity identifies distinct stages of neural patterning in the rat
     American Journal of Anatomy, vol. 200, no. 3, pp. 227–241, 1994
110. Regulation of perfluorooctanoic acid–induced peroxisomal enzyme activities and hepatocellular growth by adrenal hormones
     Hepatology, vol. 15, no. 2, pp. 316–322, 1992
111. Cytotoxicity, genotoxicity and transforming activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat tracheal epithelial cells
     Mutation Research/Genetic Toxicology, vol. 261, no. 4, pp. 249–259, 1991
112. Relationship of hepatocarcinogenicity and hepatocellular proliferation induced by mutagenic noncarcinogens vs carcinogens *1II. 1- vs 2-nitropropane
     Toxicology and Applied Pharmacology, vol. 110, no. 3, pp. 505–513, 1991
113. Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen: Carcinogen pair?2,6- and 2,4-diaminotoluene
     Toxicology and Applied Pharmacology, vol. 107, no. 3, pp. 562–567, 1991
114. Evidence for an acetoxyarylamine as the ultimate mutagenic reactive intermediate of the carcinogenic aromatic amine 2,4-diaminotoluene
     Mutation Research/Genetic Toxicology, vol. 242, no. 2, pp. 101–110, 1990
115. The interaction of methanol, rat-liver S9 and the aromatic amine 2,4-diaminotoluene produces a new mutagenic compound
     Mutation Research Letters, vol. 244, no. 4, pp. 273–277, 1990
116. Activation of methanol by hepatic postmitochondrial supernatant: formation of a condensation product with 2,4-diaminotoluene
     Chemical Research in Toxicology, vol. 3, no. 2, pp. 157–161, 1990
117. Identification and Mutagenicity of the Urinary Metabolites of the Mutagenic Noncarcinogen 2,6-Diaminotoluene
     Journal of Liquid Chromatography & Related Technologies, vol. 12, no. 8, pp. 1407–1416, 1989